US · Healthcare

Astria Therapeutics Inc (ATXS)

Biotechnology

Astria Therapeutics Inc (ATXS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ATXS

P/E ratio

18.00

Astria Therapeutics Inc (ATXS) — FAQ

What is ATXS's P/E ratio?

The price-to-earnings (P/E) ratio for Astria Therapeutics Inc (ATXS) is 18.00 (data as of 2026-03-23).

Does Astria Therapeutics Inc pay a dividend?

Dividend yield is not available in the current snapshot for Astria Therapeutics Inc (ATXS). Check the MyAverix Finance app for the latest dividend data.

What sector is Astria Therapeutics Inc in?

Astria Therapeutics Inc (ATXS) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ATXS listed on?

ATXS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)